Evidence map›Paper›PMID 38812916›Full record

ArticleFrontiers in bioengineering and biotechnology2024

Genetic engineering of a thermophilic acetogen,

Junya Kato, Tatsuya Fujii, Setsu Kato, Keisuke Wada, Masahiro Watanabe, Yusuke Nakamichi, Yoshiteru Aoi, Tomotake Morita, Katsuji Murakami, Yutaka Nakashimada

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Metabolic engineering ofMetabolic engineering communications · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junya Kato *Graduate School of Integrated Sciences for Life, Hiroshima University, Higashihiroshima, Hiroshima, Japan.
Tatsuya Fujii *National Institute of Advanced Industrial Science and Technology (AIST), Higashihiroshima, Hiroshima, Japan.
Setsu KatoGraduate School of Integrated Sciences for Life, Hiroshima University, Higashihiroshima, Hiroshima, Japan.
Keisuke WadaNational Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan.
Masahiro WatanabeNational Institute of Advanced Industrial Science and Technology (AIST), Higashihiroshima, Hiroshima, Japan.
Yusuke NakamichiNational Institute of Advanced Industrial Science and Technology (AIST), Higashihiroshima, Hiroshima, Japan.
Yoshiteru AoiGraduate School of Integrated Sciences for Life, Hiroshima University, Higashihiroshima, Hiroshima, Japan.
Tomotake MoritaNational Institute of Advanced Industrial Science and Technology (AIST), Higashihiroshima, Hiroshima, Japan.
Katsuji MurakamiNational Institute of Advanced Industrial Science and Technology (AIST), Higashihiroshima, Hiroshima, Japan.
Yutaka NakashimadaGraduate School of Integrated Sciences for Life, Hiroshima University, Higashihiroshima, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetogens are among the key microorganisms involved in the bioproduction of commodity chemicals from diverse carbon resources, such as biomass and waste gas. Thermophilic acetogens are particularly attractive because fermentation at higher temperatures offers multiple advantages. However, the main target product is acetic acid. Therefore, it is necessary to reshape metabolism using genetic engineering to produce the desired chemicals with varied carbon lengths. Although such metabolic engineering has been hampered by the difficulty involved in genetic modification, a model thermophilic acetogen,

Indexed as

acetoinbiomassC4 chemicalsgaseous substratesgenetic engineeringthermophilic acetogen

Identifiers

PMID38812916
PMCPMC11133584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.